Chris A. Rallis - 18 Jul 2022 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A Rallis, Director
Issuer symbol
FENC
Transactions as of
18 Jul 2022
Net transactions value
-$24,339
Form type
4
Filing time
18 Jul 2022, 18:00:39 UTC
Previous filing
16 Jun 2022
Next filing
20 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Options Exercise $5,000 +11,111 +53% $0.4500* 32,036 18 Jul 2022 Direct F1
transaction FENC Common Shares Tax liability $29,339 -4,379 -14% $6.70 27,657 18 Jul 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options granted on August 17, 2012, with a $0.45 USD strike price and an expiration of August 17, 2022.
F2 Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 11,111 shares from an August 17, 2012 grant.